Tumor Seeding With Needle Biopsy of Hepatocellular Carcinoma: A Systematic Review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 39692333.
- Also identified by DOI 10.14309/ajg.0000000000003210.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biopsy of hepatocellular carcinoma (HCC) may help with selecting appropriate chemotherapy with inconclusive imaging; concern about potential seeding may limit its use. A systematic review was conducted to assess the risk of tumor seeding with biopsy of HCC excluding nonliver cancers or seeding after interventions. A total of 2,339 unique abstracts were identified; 37 studies were included in the final analysis. The rate of tumor seeding was 0.62% (range 0%-7.77%) in 13,959 biopsies performed. The average reported median lengths of follow-up was 35.8 months (range 10.5-60 months). Overall, the risk of tumor seeding with biopsy of HCC is low.
Medical subject headings
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Neoplasm Seeding